书目名称 | Microarray Technology and Cancer Gene Profiling | 编辑 | Simone Mocellin | 视频video | http://file.papertrans.cn/633/632852/632852.mp4 | 概述 | Each chapter is written by a leader in the field.Contains detailed illustrations | 丛书名称 | Advances in Experimental Medicine and Biology | 图书封面 |  | 描述 | .Cancer is a heterogeneous disease in most respects, including its cellularity, different genetic alterations and diverse clinical behaviors. Traditional molecular analyses are reductionist, assessing only one or a few genes at a time, thus working with a biologic model too specific and limited to confront a process whose clinical outcome is likely to be governed by the combined influence of many genes. The potential of functional genomics is enormous, because for each experiment, thousands of relevant observations can be made simultaneously. Accordingly, DNA array, as other high throughput technologies, might catalyze and ultimately accelerate the development of knowledge in tumor cell biology. Although in its infancy, the implementation of DNA array technology in cancer research has already provided investigators with novel data and intriguing new hypotheses on the molecular cascade leading to cancerogenesis, tumor aggressiveness and sensitivity to antineoplastic agents. Given the revolutionary implications that the use of this technology might have in the clinical management of cancer patients, principles of DNA array-based tumor gene profiling need to be clearly understood for | 出版日期 | Book 2007 | 关键词 | DNA; Microarray; PCR; SNP; Tumor; classification; gene expression; genes; genome | 版次 | 1 | doi | https://doi.org/10.1007/978-0-387-39978-2 | isbn_softcover | 978-1-4419-2298-4 | isbn_ebook | 978-0-387-39978-2Series ISSN 0065-2598 Series E-ISSN 2214-8019 | issn_series | 0065-2598 | copyright | The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Busines |
The information of publication is updating
|
|